OGT’s Dr John Anson discusses the evolving field of biomarker discovery

The field of biomarker discovery is advancing rapidly as we move towards the era of personalised medicine. Hear Dr. John Anson, Vice President Biomarker Discovery, OGT and Dr. Arif Anwar, Chief Operating Officer, Sengenics discuss the application and future of biomarker discovery with Meera Sivasothy of Malaysia’s business radio station BFM.

Listen to the interview.

Find out more about OGT’s integrated biomarker discovery solutions.

• Sign up to E-News

  Get the latest information in your area of interest.

  Sign up now
• Rare disease & trio sequencing

  A unique rare disease sequencing and analysis service allowing rapid generation of a shortlist of candidate mutations.

  Discover more